Copyright © 2000 by the European Society of Cardiology.
Letters to the Editor
A reply
a Cardiovascular Pathophysiology Research Centre, Salvatore Maugeri Foundation for Care and Research, Gussago, Brescia, Italy
b DIBIT, San Raffaele Scientific Institute, Milan, Italy
c Arcispedale S. Anna, University of Ferrara, Department of Clinical Medicine, Ferrara, Italy
References
- Ferrari, R, Bachetti, T, Confortini, R, Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation, 1995, 92, 1479, 86
- Agnoletti L, Curello S, Bachetti T. Serum from patients with severe heart failure downregulates eNOS and is proapoptotic-Role of tumor necrosis factor-
. Circulation. 1999;100:19831991[Abstract/Free Full Text] - Bryant D, Becker L, Richardson J. Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-
. Circulation. 1998;97:13751381[Abstract/Free Full Text] - Torre-Amione G, Stetson SJ, Younker KA, Durand JB, Radavancevic B, Delgado RM, Frazier OH, Entman ML, Noon GP. Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support: A potential mechanism for cardiac recovery. Circulation. 1999;100:11891193
[Abstract/Free Full Text] - Comini L, Bachetti T, Agnoletti L. Induction of functional nitric oxide synthase in monocytes of patients with congestive heart failure. Eur Heart J. 1999;20:15031513
[Abstract/Free Full Text] - Smith RA, Baglioni C. The active form of tumor necrosis factor is a trimer. J Biol Chem. 1987;262:69516954
[Abstract/Free Full Text] - Corti A, Fassina G, Marcucci F, Barbanti E, Cassani G. Oligomeric tumour necrosis factor alpha slowly converts into inactive forms at bioactive levels. Biochem J. 1992;284:905910
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||